USC Norris Comprehensive Cancer Center - Keck School of Medicine

University of Southern California

Los Angeles, CA
Website
(888) 828-2206

Sorting 3 by

Accepting patients

iMMagine-3

A Phase 3, Randomized, Open-Label Study to Compare the Efficacy and Safety of Anitocabtagene Autoleucel Versus Standard of Care Therapy in Participants With Relapsed/Refractory Multiple Myeloma
Learn more
  • CAR T Cell
  • BCMA
  • Randomization
  • Phase 3

Accepting patients

AMBUSH

Bortezomib and Pembrolizumab With or Without Pelareorep for the Treatment of Relapsed or Refractory Multiple Myeloma, AMBUSH Trial
Learn more
  • Checkpoint Inhibitor
  • Reovirus
  • PD-1
  • Phase 2
Get personalized results in 60 seconds
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trials

Not yet accepting

QXL138AM

A First-in-human Phase 1a/1b Study to Evaluate Safety and Tolerability of QXL138AM in Patients With Locally Advanced Un-resectable and/or Metastatic Solid Tumors and Multiple Myeloma
Learn more
  • Masked Immunocytokine (MIC)
  • CD138
  • Phase 1
1 hidden based on your filters. Show All